WALPHARMA
ActiveSummary
WALPHARMA has been active since 1990 and the Belgian Official Gazette contains no insolvency signals. The CBE does carry 1 administrative register entry (see administrative flags). The 2024 annual accounts show equity of €98,407 and a net result of -€27,936. Equity is shrinking by about 19% per year across the filed financial years. Its solvency ranks better than 64% of 26,023 sector peers (NACE 47, financial year 2024). The computed 12-month bankruptcy probability is 0.9% (low).
History
Acts, filings and financial milestones
2025
31-08
NBB filing
Annual accounts filed
financial year 2024 · micro format · 31 days late
2024
29-08
NBB filing
Annual accounts filed
financial year 2023 · micro format · 29 days late
08-03
KBO administration
Strikeout withdrawn
event 27-02-2024
27-02
NBB filing
Annual accounts filed
financial year 2022 · micro format · 211 days late
2023
27-09
NBB filing
Annual accounts filed
financial year 2021 · micro format · 423 days late
27-09
NBB filing
Annual accounts filed
financial year 2020 · micro format · 788 days late
27-09
NBB filing
Annual accounts filed
financial year 2019 · micro format · 1153 days late
2021
31-12
Financial
Weakest financial yearnet -€75,529
Net result drops to -€75,529, the lowest in the series; recovery starts the following year.
2018
28-09
NBB filing
Annual accounts filed
financial year 2017 · micro format · 59 days late
2016
31-08
NBB filing
Annual accounts filed
financial year 2015 · full format · 31 days late
2015
31-08
NBB filing
Annual accounts filed
financial year 2014 · full format · 31 days late
2014
30-08
NBB filing
Annual accounts filed
financial year 2013 · full format · 30 days late
SignalFinancial milestoneNBB filingFinancial milestones sit on the financial year-end date, not the filing date.Of the 31 annual accounts filed, the latest 10 are here; all are under Financials.
0 of 1 deed read
About the unread acts
We know of 1 Belgian Official Gazette act for this company. It has not been read yet: what they contain is neither established nor disproved here.
Have them read with priority
Sign in to place this company at the front of the reading queue.